Condition
Ectopic ACTH Syndrome
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (2)
Trial Status
Withdrawn1
Terminated1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05804669Phase 1Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
NCT02780882Phase 2WithdrawnPrimary
SOM230 Ectopic ACTH-producing Tumors
NCT00958841Phase 2Terminated
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Showing all 3 trials